Low cost Ayurvedic medicine on diabetes launched

Image
Press Trust of India Patna
Last Updated : Jan 08 2016 | 8:13 PM IST
A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organizations for diabetes patients.
The medicine named "BGR-34" has been developed jointly by CSIR-NBRI (National Botanical Research Institute) Lucknow and CSIR-CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow).
The medicine was launched here yesterday at the presence of A K S Rawat-Principal Senior Scientist CSIR- National Botanical Research Institute, Lucknow and D N Mani Senior Scientist CSIR-Central Institute for Medicinal And Aromatic Plants, Lucknow.
It would help maintain normal Blood Glucose Metabolism and also reduce chances of long term complications, they said.
AIMIL Pharmaceuticals, a private company, has been given the marketing right of the Ayurvedic proprietary medicine, a company release said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 08 2016 | 8:13 PM IST

Next Story